Manufacturing Partner

Nicoasia International

Premium veterinary pharmaceutical manufacturer producing state-of-the-art medicines, anti-infectives, and therapeutic treatments. Headquartered in Cyprus and distributed with strict quality compliance across UAE & Oman.

Country of Origin: CyprusSpecialization: Pharmaceuticals & Anti-infectives

Company Overview

Nicoasia International is a premier pharmaceutical enterprise based in Cyprus, dedicated to formulating and manufacturing high-grade veterinary medicines, chemotherapeutic agents, and targeted anti-infectives. Operating under stringent European Union Good Manufacturing Practices (EU-GMP), Nicoasia leverages pharmaceutical innovation to combat systemic infectious diseases in commercial livestock, poultry, and equine species.

With robust molecular testing and stable delivery mechanisms, Nicoasia's injectable and oral therapeutics are designed for maximum bioavailability, ensuring rapid recovery and minimal withdrawal periods for food-producing animals.

Product Range & Therapeutic Verticals

Nicoasia's product range specializes in veterinary pharmaceutical efficacy:

Broad-Spectrum Injectable Antibiotics

Targeted Anti-Infectives

Soluble Antimicrobial Powders

Systemic Chemotherapeutics

Gastrointestinal Formulations

Therapeutic Oral Suspensions

Why MAAT Partners with Nicoasia

Our partnership with Nicoasia is centered around therapeutic reliability and strict product safety. MAAT partners with them because of:

EU-GMP Standard
Manufactured under European regulations, offering premium safety assurances.
High Bioavailability
Injectables formulated for fast clinical onset and rapid disease containment.
Comprehensive Regulatory Support
Streamlined data packages for MOCCAE medicine registrations.
Trusted Delivery
Long-standing supply reliability serving key clinics across UAE & Oman.

Inquire About Nicoasia Products

PRODUCT PORTFOLIO